Trietanolammina 99.0-103.0% (by acidimetry), SAFC®
Fornitore: MERCK PRODUCTION CHEMICALS
Synonyms:
Tris-(2-hydroxyethyl)amine, 2,2',2''-Nitrilotriethanol
1.08372.1000
1.08372.6025
1.08372.6180
1.08372.1000EA
449
EUR
1.08372.1000
1.08372.6025
1.08372.6180
Trietanolammina 99.0-103.0% (by acidimetry), SAFC®
Trietanolammina
Formula:
C₆H₁₅NO₃ Peso molecolare: 149,19 g/mol Punto di ebollizione: 335,4 °C (1013 hPa) Punto di fusione: 21,6 °C Densità: 1,13 g/cm³ (20 °C) Flash Pt: 179 °C (coppa chiusa) Temperatura di stoccaggio: Ambiente |
MDL Number:
MFCD00002855 CAS Number: 102-71-6 EINECS: 203-049-8 Merck Index: 13,09739 |
Risultati del test di specificazione
Assay (acidimetric, calc. on anhydrous substance) | 99.0 - 103.0 % |
Identity (IR-spectrum) | passes test |
Identity (GC) | conforms |
Appearance | colorless to slightly yellow viscose liquid |
Appearance of solution | Clear and not more intense in colour than reference solution B₆ |
Clarity of solution | passes test |
PH (1.0 g in 10 ml water) | 10.5 - 11.5 |
Refractive index (n 20/D) | 1.482 - 1.485 |
Relative Density (d 20/20) | 1.120 - 1.130 |
Relative Density (d 25/25) | 1.120 - 1.128 |
Heavy metals (as Pb) | ≤ 0.0010 % |
As (Arsenic) | ≤ 0.000075 % |
Fe (Iron) | ≤ 0.0005 % |
Related substances (Ethanolamine, GC) | ≤ 0.1 % |
Related substances (Diethanolamine, GC) | ≤ 0.5 % |
Related substances (total impurity, GC) | ≤ 1.0 % |
Related substances (N-Nitrosodiethanolamine, GC) | ≤ 24 ppb |
Residual solvents (ICH Q3C) | ...excluded by production process |
Sulfated ash (600 °C) | ≤ 0.05 % |
Water (according to Karl Fischer) | ≤ 0.5 % |
Endotoxins | ≤ 2.5 I.U./ml |
Elemental impurity specifications have been set considering ICH Q3D (Guideline for Elemental Impurities). Class 1-3 elements are not likely to be present above the ICH Q3D option 1 limit, unless specified and indicated (*). | |
N-Nitrosodiethanolamine (GC) test performed by a qualified external laboratory. | |
Meets analytical specifications of Ph Eur, JPE, NF. | |
The information provided does not imply the suitability of the product for pharmaceutical applications. It is customer's sole responsibility, prior to use, to determine that the product is suitable and permitted for the customer's intended use and application. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...